Ipilimumab vs Oxycodone
Ipilimumab vs Oxycodone: Overview
This comparison examines the pharmacological differences between Ipilimumab and Oxycodone.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Oxycodone: Semisynthetic mu-opioid receptor agonist.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Oxycodone β 3-5 hours.
Chemical Properties
Molecular Formula: Oxycodone β C18H21NO4.
Molecular Weight: Oxycodone β 315.3640 g/mol.
Type: Ipilimumab β Antibody; Oxycodone β Small molecule.